$GALT insiders have traded $GALT stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales. Here’s a ...
On Friday, Galectin Therapeutics, Inc. (NASDAQ:GALT) released results from its global Phase2/3 NAVIGATE trial evaluating belapectin in patients with Metabolic Dysfunction-Associated Steatohepatitis ...
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...
View Galectin Therapeutics Inc. GALT stock quote prices, financial information, real-time forecasts, and company news from CNN.
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immuneering , Galectin Therapeutics and Dexcom with bullish sentiments. Claim 55% ...
Hosted on MSN
Why did GALT shares plummet over 30% today?
・Following the written FDA response, the company believes there is alignment with the agency on the proposed patient population for enrollment in its registration trial. ・The company also plans to ...
In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. Galectin Therapeutics Inc. is one of them. Galectin Therapeutics Inc. (NASDAQ:GALT) is a ...
Galectin Therapeutics (NASDAQ:GALT) Stock, Option Chain Option chain shows key data for Galectin Therapeutics's stock options at various strike prices and expiration dates. Traders use this ...
Galectin Therapeutics (NASDAQ:GALT) submits a Fast Track application for the clinical development of the fatty liver disease treatment GR-MD-02 which has shown some promise in reversing fibrosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results